Sagimet Biosciences Files 8-K Report
Ticker: SGMT · Form: 8-K · Filed: Mar 12, 2025 · CIK: 1400118
Sentiment: neutral
Topics: 8-K, financial-reporting, corporate-update
TL;DR
Sagimet Biosciences dropped an 8-K on March 12th – check it for financial and operational updates.
AI Summary
On March 12, 2025, Sagimet Biosciences Inc. filed an 8-K report detailing results of operations and financial condition, along with other events and financial statements. The company, formerly known as 3-V Biosciences, Inc., is incorporated in Delaware and headquartered in San Mateo, California.
Why It Matters
This filing provides an update on Sagimet Biosciences' operational and financial status, which is crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing standard corporate information and financial updates, not indicating any immediate or significant risks.
Key Players & Entities
- Sagimet Biosciences Inc. (company) — Registrant
- 3-V Biosciences, Inc. (company) — Former company name
- March 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Mateo, California (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Sagimet Biosciences Inc.?
The primary purpose of this 8-K filing is to report on Sagimet Biosciences Inc.'s results of operations and financial condition, as well as other events and financial statements.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 12, 2025.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Sagimet Biosciences Inc.
In which state was Sagimet Biosciences Inc. incorporated?
Sagimet Biosciences Inc. was incorporated in Delaware.
What is the address of Sagimet Biosciences Inc.'s principal executive offices?
The address of Sagimet Biosciences Inc.'s principal executive offices is 155 Bovet Road, Suite 303, San Mateo, California 94402.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 12, 2025 regarding Sagimet Biosciences Inc. (SGMT).